Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-CD36 Polyclonal Antibody

Catalog #:   PHD19101 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P16671
Overview

Catalog No.

PHD19101

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human CD36 (Leu187-Asn428).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

CD36,FAT,GPIV,Fatty acid translocase,GP4,PAS IV,Leukocyte differentiation antigen CD36,Platelet collagen receptor,Platelet glycoprotein IV,Thrombospondin receptor,Platelet glycoprotein 4,GP3B,Glycoprotein IIIb,GPIIIB,PAS-4

Purification

Purified by antigen affinity column.

Accession

P16671

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with CD36 antibody (PHD19101) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 30 kDa
    Observed MW: 30 kDa
  • Western Blot
    Various lysates were subjected to SDS PAGE followed by western blot with CD36 antibody (PHD19101) at 1 μg/ml.

    Lane 1: RAW264.7

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 53 kDa
    Observed MW: 88 kDa
  • Immunohistochemical
    Immunohistochemical analysis of rat heart stained for CD36 with PHD19101.
References

Phenotypic Shifts in Macrophages Within Advanced Atherosclerotic Plaques in Humans., PMID:40496346

Plasmodium falciparum expresses fewer var genes at lower levels during asymptomatic dry season infections than clinical malaria cases., PMID:40493675

Comparison of the Mutational Profile between BCL2- and BCL6-Rearrangement Positive Follicular Lymphoma., PMID:40482882

Predicting Clinical Response to Monoclonal TNF Inhibitors in Rheumatoid Arthritis: A Transcriptomic Approach Based on Transmembrane TNF Reverse Signaling and Nrf2 Activation., PMID:40428231

Ertugliflozin attenuates atherosclerosis in nondiabetic ApoE-/- mice by upregulating ABCA1 and LDLR via the PPARγ/LXRα pathway., PMID:40419168

Inhibition of terminal complement complex formation alleviates murine antibody-mediated TRALI., PMID:40388640

Effects of micro- and nanoplastic exposure on macrophages: a review of molecular and cellular mechanisms., PMID:40323219

PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis., PMID:40294022

Targeting the tumour cell surface in advanced prostate cancer., PMID:40169837

28-color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease., PMID:40134341

Management challenge of a rare concomitant platelet glycoprotein IV/CD36 and IIb/IIIa deficiencies: Case illustration., PMID:40033798

Discovery and in vitro characterization of a human anti-CD36 scFv., PMID:39967671

CD36 as a Therapeutic Target in Tumor Microenvironment and Lipid Metabolism., PMID:39754780

Monocyte-cancer cell fusion is mediated by phosphatidylserine-CD36 receptor interaction and induced by ionizing radiation., PMID:39752516

Downregulation of CD36 alleviates IgA nephropathy by promoting autophagy and inhibiting extracellular matrix accumulation in mesangial cells., PMID:39616852

Comparative analysis of Lox-1 and CD36 expression in human platelets and on circulating microparticles during ARDS-induced coagulopathy., PMID:39546984

Monocyte CD36 Expression Predicts Disease Activity in Patients With Crohn's Disease., PMID:39524404

Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia., PMID:39477946

Efferocytosis dysfunction in CXCL4-induced M4 macrophages: phenotypic insights in systemic sclerosis in vitro and in vivo., PMID:39464886

Histologic Characterization of Tumor-Adjacent Mammary Adipose Tissue in Normal-Weight and Overweight/Obese Patients with Triple-Negative Breast Cancer., PMID:39456610

[Preparation and preliminary identification of Fc-silent anti-human CD36 chimeric antibody]., PMID:39442990

Bach2 repression of CD36 regulates lipid-metabolism-linked effector functions in follicular B cells., PMID:39412989

The GPI sidechain of Toxoplasma gondii inhibits parasite pathogenesis., PMID:39302131

Dysmetabolism of Peripheral Blood Monocytes in Type 1 Diabetes Mellitus., PMID:39264558

Serum amyloid A1 induced dysfunction of airway macrophages via CD36 pathway in allergic airway inflammation., PMID:39244902

Children with hemoglobin C or S trait have low serologic responses to a subset of malaria variant surface antigens., PMID:39216830

CD36 antibodies in isoimmunized African-origin pregnant women: three years experience in Spain., PMID:39133626

CX-5461 ameliorates disease in lupus-prone mice by triggering B-cell ferroptosis via p53-SLC7A11-ALOX12 pathway., PMID:39111584

CD36: a promising therapeutic target in hematologic tumors., PMID:38982639

Protein-energy restriction-induced lipid metabolism disruption causes stable-to-progressive disease shift in Mycobacterium avium-infected female mice., PMID:38889480

Release of CD36-associated cell-free mitochondrial DNA and RNA as a hallmark of space environment response., PMID:38862469

Pioglitazone Alleviates β1-Adrenergic Receptor Antibody-Induced Atrial Fibrillation Susceptivity via Mitigation of PPAR-γ-Mediated Metabolic Inflexibility., PMID:38818915

Unveiling the hidden role of the interaction between CD36 and FcγRIIb: implications for autoimmune disorders., PMID:38762740

Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism., PMID:38754290

CyTOF analysis revealed platelet heterogeneity in breast cancer patients received T-DM1 treatment., PMID:38643891

Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages., PMID:38560051

Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement., PMID:38462571

Stromal thrombospondin 1 suppresses angiogenesis in oral submucous fibrosis., PMID:38403794

High-Throughput CD36 Phenotyping on Human Platelets Based on Sandwich ELISA and Mutant Gene Analysis., PMID:38314240

CD36 regulates macrophage and endothelial cell activation and multinucleate giant cell formation in anti neutrophil cytoplasm antibody vasculitis., PMID:38286173

The regulatory role of CD36 in hematopoiesis beyond fatty acid uptake., PMID:38244916

The oxidized phospholipid PGPC impairs endothelial function by promoting endothelial cell ferroptosis via FABP3., PMID:38218337

Soluble CD83 modulates human-monocyte-derived macrophages toward alternative phenotype, function, and metabolism., PMID:38162675

Vaccination against the HDL receptor of S. japonicum inhibits egg embryonation and prevents fatal hepatic complication in rabbit model., PMID:38019787

Single-cell RNA-sequencing atlas reveals an FABP1-dependent immunosuppressive environment in hepatocellular carcinoma., PMID:38007237

Study on the Treatment of ITP Mice with IVIG Sourced from Distinct Sex-Special Plasma (DSP-IVIG)., PMID:37958975

The role of CD36 antibodies in haematopoietic stem cell transplantation., PMID:37953653

Thrombospondin-1 proteomimetic polymers exhibit anti-angiogenic activity in a neovascular age-related macular degeneration mouse model., PMID:37831763

An optimized procedure for Luminex-based human platelet antigen-specific antibody screening and identification (PakLx assay) with a cost-effective approach and improved sensitivity., PMID:37811680

Antibody binding activity specific to monocyte scavenger receptor CD36 is frequently detectable in the plasma of patients with antiphospholipid syndrome., PMID:37715736

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CD36 Polyclonal Antibody [PHD19101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only